Analysis of Ramston's RFX, Essen-New Lender, and Fever Tree Company

This chapter delves into Graham's insightful notes on Ramston's RFX and Essen-New, discussing his cautious approach following recent findings. They also briefly review Fever Tree's financial outlook and express apprehensions about its valuation and earnings forecasts.